Photochemical toxicity of drugs intended for ocular use

Arhiv za Higijenu Rada i Toksikologiju

Volumn 65, Issue 2, 2014, Pages 157-167

  Sahu, Roshan Kumar ^a,b   Singh, Bhupendra ^a   Saraf, Shubhini A ^a   Kaithwas, Gaurav ^a   Kishor, Kamal ^c  

^a BABASAHEB BHIMRAO AMBEDKAR UNIVERSITY   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

Antibacterial agents; Antifungal agents; HET CAM Test; ICE Test; NSAIDs; RBC Test

Indexed keywords

DICLOFENAC; KETOCONAZOLE; KETOROLAC; SULFACETAMIDE; VORICONAZOLE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; EYE DROPS; IRRITANT AGENT;

ARTICLE; BLOOD SAMPLING; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; CORNEA THICKNESS; DRUG USE; ERYTHROCYTE; EYE EXAMINATION; EYE TOXICITY; FEMALE; HEMOLYSIS; NONHUMAN; PHOTOTOXICITY; PROTEIN DENATURATION; SUNLIGHT; TOXICITY TESTING; ANIMAL; EYE DISEASES; HUMAN; PHOTOCHEMISTRY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CHICKENS; DICLOFENAC; EYE DISEASES; HUMANS; IRRITANTS; KETOCONAZOLE; KETOROLAC; OPHTHALMIC SOLUTIONS; PHOTOCHEMICAL PROCESSES; SULFACETAMIDE; VORICONAZOLE;

EID: 84908037395     PISSN: 00041254     EISSN: 18486312     Source Type: Journal    
DOI: 10.2478/10004-1254-65-2014-2461     Document Type: Article

References (24)

1. Organisation for Economic Cooperation and Development (OECD). Guidelines for the Testing of Chemicals No. 405: Acute Eye Irritation/Corrosion. Paris: OECD; 2002.
2. Furrer P, Mayer JM, Gurny R. Ocular tolerance of preservatives and alternatives. Eur J Pharm Biopharm 2002;53:263-80. doi: 10.1016/S0939-6411(01)00246-6
3. Benavides T, Martínez V, Mitjans M, Infante MR, Moran C, Clapés P, Clothier R, Vinardell MP. Assessment of the potential irritation and photoirritation of novel amino acid-based surfactants by in vitro methods as alternative to the animal tests. Toxicology 2004;201:87-93. doi: 10.1016/j. tox.2004.04.003
4. ICCVAM Test Method Evaluation Report: Appendix G-ICCVAM Recommended HET-CAM Test Method Protocol, 2006 [displayed 2 May 2014]. Available at http://ntp.niehs. nih.gov/iccvam/docs/ocutox-docs/oteval/appg-508.pdf
5. ICCVAM-Recommended Protocol for Using the Isolated Chicken Eye (ICE) Test Method Protocol, 2012 [displayed 2 May 2014]. Availalble at http://ntp.niehs.nih.gov/iccvam/docs/protocols/iceprotocol16jul12v2-508.pdf
6. Organisation for Economic Cooperation and Development (OECD). Guidelines for the Testing of Chemicals No 438: Isolated Chicken Eye Test Method for Identifying Ocular Corrosives and Severe Irritants. Paris: OECD; 2009.
7. Velpandian T, Bankoti R, Humayun S, Ravi AK, Kumari SS, Biswas NR. Comparative evaluation of possible ocular photochemical toxicity of fuoroquinolones meant for ocular use in experimental models. Indian J Exp Biol 2006;44:387-91. PMID: 16708892
8. INVITTOX Protocol No 37, European Centre for the Validation of Alternative Methods RBC Test System, Ispra: ECVAM DB-ALM; 2010.
9. Editors. Artifacts of light. Nat Meth. 2013;10:1135. doi: 10.1038/nmeth.2760
10. Ahmad T, Ahmed I. Multicomponent spectrophotometric assay of sulphacetamide and photodegradation products. Pak J Pharm Sci 1990;3:29-39. PMID:16414659
11. Miyazaki T, Yomota C, Okada S. Depolymerization of hyaluronate by the phototoxic drugs phenothiazines and sulphacetamide. Colloid Polymer Sci 2000;278:84-9. doi: 10.1007/s003960050014
12. Jordan L. Holtzman. Role of reactive oxygen and metabolite binding in drug toxicity. Life Sci 1982;30:1-9. doi: 10.1016/0024-3205(82)90629-4
13. Mhaske RA, Sahasrabudhe S. Identification of Major Degradation Products of Ketoconazole. Sci Pharm 2011;79:817-36. doi: 10.3797/scipharm.1107-18
14. Mohamed KN. Severe photodermatitis during ketoconazole therapy. Clin Exp Derm 1988;13:54. PMID: 3208444
15. Murayama N, Imai N, Nakane T, Shimizu M, Yamazaki H. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes. Biochem Pharmacol 2007;73:2020-6. doi: 10.1111/j.1365-2125.2009.03534.x
16. 2 and ozone. Water Res 2004;38:414-22. doi: 10.1016/j.watres.2003.09.028
17. Roberts JE. Ocular phototoxicity. J Photochem Photobiol B 2001;64:136-43. doi: 10.1016/S1011-1344(01)00196-8
18. Motten AG, Chignell CF. Spectroscopic studies of cutaneous photosensitizing agents-III. Spin trapping of photolysis products from sulphanilamide analogs. Photochem Photobiol 1983;37:17-26. PMID: 6300940
19. Staub I, Flores L, Gosmann G, Pohlmann A, Fröehlich PE, Schapoval EES, Bergold AM. Photostability studies of ketoconazole: isolation and structural elucidation of the main photodegradation products. Latin Am J Pharm 2010;29:1100-6.
20. Adams AIH, Grace G, Paulo HS, Ana MB. LC stability studies of voriconazole and structural elucidation of its major degradation product. Chromatographia 2009;69(Supplement):115-22. doi: 10.1365/s10337-009-1082-3
21. Epaulard O, Saint-Raymond C, Villier C, Charles J, Roch N, Beani JC, Leccia MT. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients. Clin Microbiol Infect 2010;16:1362-4. doi: 10.1111/j.1469-0691.2009.03124.x
22. Scholz I, Oberwittler H, Riedel KD, Burhenne J, Weiss J, Haefeli WE, Mikus G. Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype. Br J Clin Pharmacol 2009;68:906-15. doi: 10.1111/j.1365-2125.2009.03534.x
23. Encinas S, Bosca F, Miranda MA. Phototoxicity associated with diclofenac: a photophysical, photochemical, and photobiological study on the drug and its photoproducts. Chem Res Toxicol 1988;11:946-52. doi: 10.1021/tx9800708
24. Leo G, Hi-Shi C, Johanson D. Light degradation of ketorolac tromethamine. Int J Pharmaceutics 1988;41:105-13. doi:10.1016/0378-5173(88)90142-1.